Results 81 to 90 of about 25,756 (267)

Hypopituitarism in Childhood [PDF]

open access: yesCancer Control, 2002
Background Childhood hypopituitarism may be present at birth or may be acquired. Early diagnosis and treatment promote the best possible outcomes. Methods The anatomy, etiologies, clinical presentation, diagnostic testing strategies, and current treatments relevant to childhood hypopituitarism are reviewed.
openaire   +2 more sources

GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab

open access: yesCancer Science, Volume 116, Issue 12, Page 3300-3308, December 2025.
This study highlights the importance of germline genetic markers in predicting severe trAEs caused by nivolumab. Our findings support their potential to guide personalized immunotherapy and improve treatment safety and efficacy in advanced ccRCC and other cancers.
Tokiyoshi Tanegashima   +26 more
wiley   +1 more source

Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study

open access: yesBMC Medical Education
Background Hypopituitarism, including growth hormone deficiency (GHD), is a common sequela of traumatic brain injury (TBI). This study explored the coverage of education and training of TBI-induced hypopituitarism in general and GHD in particular, in ...
Javier Cárdenas   +3 more
doaj   +1 more source

Development of a Minimum Dataset for the Global Monitoring of the Safety and Efficacy of Growth Hormone Replacement in Adults With Growth Hormone Deficiency (AGHD)

open access: yesClinical Endocrinology, Volume 103, Issue 6, Page 841-851, December 2025.
ABSTRACT Objective To identify the minimum dataset (MDS) for the monitoring of safety and effectiveness of GH in adults with growth hormone deficiency (AGHD). Design Systematic review and expert consensus. Methods Outcomes for AGHD were identified through a systematic literature search in PubMed, Science Direct and Cochrane.
Suet Ching Chen   +26 more
wiley   +1 more source

Traumatic Brain Injury and Hypopituitarism

open access: yesThe Scientific World Journal, 2005
Results of recent and ongoing studies have made it clear that brain injuries like Traumatic Brian Injury (TBI) pose substantial risk to pituitary function, perhaps even greater risk than previously believed.
Gianluca Aimaretti, Ezio Ghigo
doaj   +1 more source

Hypopituitarism after Orthohantavirus Infection: What is Currently Known?

open access: yesViruses, 2019
Several case reports have described hypopituitarism following orthohantavirus infection, mostly following Puumala virus. The pathogenesis of this seemingly rare complication of orthohantavirus infection remains unknown.
Soerajja Bhoelan   +7 more
doaj   +1 more source

A CASE OF HYPOGLYCEMIA… [PDF]

open access: yes, 2016
Introdução: O hipopituitarismo é caracterizado por insuficiência da secreção hormonal hipófisária. A clínica é variável e depende da etiologia, evolução temporal e hormonas envolvi- das.
Afonso, Ariana   +6 more
core  

Sucessful Transition in Rare Endocrine Diseases: Patient Experiences in a French Reference Centre

open access: yesClinical Endocrinology, Volume 103, Issue 6, Page 833-840, December 2025.
ABSTRACT Objective This study aimed to evaluate the experiences of patients who had a joint endocrinology consultation for transition to adult care at Marseille university hospitals between 2010 and 2020, focusing on patient follow‐up, satisfaction, difficulties, and expectations.
Karine Aouchiche   +6 more
wiley   +1 more source

Hypopituitarism [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2013
Manuel Faria   +3 more
openaire   +3 more sources

JMT103 versus Non‐Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity Score‐Matched Comparison

open access: yesCancer Medicine, Volume 14, Issue 22, November 2025.
ABSTRACT Background Giant cell tumors of bone (GCTB) are RANK/RANK‐ligand positive, progressive osteolytic tumors. There was no medical treatment for GCTB based on efficacy and safety data from Chinese patients. A single‐arm, phase II study demonstrated the promising efficacy of JMT103 in unresectable or surgically challenging GCTB.
Hairong Xu   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy